Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Study of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
NCT06305351Phase 1Completed
- Sponsor
- Kallyope
- Start
- Dec 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of K757 and K-833 in type 2 diabetes mellitus (T2DM) and obesity, sponsored by Kallyope. Started Dec 2023; status: completed.
02
Drugs
K757K-833
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT06305351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06305351.